TransDataNexus

Resolved US healthcare and pharmaceutical intelligence layer built on a single canonical molecule key: 177 catalogued datasets on a Data Atlas spanning 1939 to 2028, 323.9 million curated records counted from the records themselves, tracking $2.21 trillion of drug spend across paid registers. Integrated content includes spending, prescribers, approvals, patents, manufacturing plants (a plant map of 9,015 facilities), payer plans, shipments, coverage and restrictions, channel mix, pricing and IRA selection risk, market share, pipeline and promotional spend, inspection citations and demand by molecule. Every figure carries source-register and vintage lineage, overlapping registers are reconciled by maximum rather than sum to prevent double counting, and the whole layer is read-only. A separate pharma Trade Intelligence layer covers global export/import shipments, exporters, buyers and prices across 180+ countries.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks TransDataNexus and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: PharmaceuticalsHealth Care Technology
Instruments: equities
Categories

Dataset card

Type: not stated
Format: Relational/warehouse tables delivered three ways: a browsable Data Atlas catalogue with per-dataset record counts, source register, vintage and integrity status; downloadable data packages formed from dataset families exported as files; and a natural-language Ask console that returns SQL-backed answers with source and vintage disclosure. Also offered as private-branded on-premises or hosted deployment with code and pipelines handed over.
Volume: Vendor-stated: 323.9 million curated records across 177 datasets, $2.21 trillion of tracked drug spend, a 9,015-plant map, and a 1939-2028 vintage window. The adjacent trade layer is separately stated at tens of millions of shipment records, 3.7 million shipments / 81k+ companies / 7,900+ drugs in one framing, and 93 data sources resolved into a linked graph described by the founder as 15+ billion linked data points.
Users: Small — plausibly tens of accounts (inferred: a ~4-person Mumbai company selling subscription tiers priced $1,500/year Startup and $4,000/year Corporate plus a 5-day free trial, so seat count follows a low-ARPU self-serve plus custom-enterprise mix)
History: 87 years
Update frequency: not stated
Growth: Active but founder-dependent and possibly transitional — the pharma product is marketed as 'Product 02', indicating a second build on top of an established trade-data product, with continuous register refreshes advertised. Materially, the founder has publicly stated he is seeking strategic investment or a complete acquisition of both the Healthcare Intelligence platform and the Trade Intelligence layer.
Launched: Trade Intelligence product first, with public content traceable to late 2024 / early 2025 (company LinkedIn activity on export data dated January 2025 and the corporate record created late 2024); the Healthcare & Pharma platform is explicitly 'Product 02', so ~2025-2026
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site